Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Respiratory Devices Market
Therapeutic Respiratory Devices Market size was worth more than USD 47 billion in 2022 and is poised to exhibit 4.7% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.
In recent years, respiratory diseases have turned to be the major cause of mortality in both developing and underdeveloped nations. There has also been a rapid rise in the number of non-contagious respiratory disorders, such as asthma, COPD, cystic fibrosis, and lung cancer. As per the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2022, more than 350 million people worldwide suffer from asthma. Furthermore, the rising levels of air pollution is increasing the burden of lung and respiratory ailments.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Therapeutic Respiratory Devices Market Size in 2022: | USD 47.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 4.7% |
2032 Value Projection: | USD 72.8 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 330 |
Tables, Charts & Figures: | 625 |
Segments covered: | Product, Application, End-use, Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Therapeutic respiratory devices play a pivotal role in managing respiratory diseases, by providing much-needed relief and improving the quality of life for patients. These devices encompass a wide range of tools, including inhalers, nebulizers, positive airway pressure machines, and oxygen concentrators. Additionally, the advent of medically advanced respiratory devices has revolutionized the treatment of respiratory diseases for improved respiratory functions and enhanced overall well-being.